Training the next generation of biomedical investigators in glycosciences
The Journal of clinical investigation, Vol.126(2), pp.405-408
02/01/2016
: 10.1172/JCI85905
: PMC4731185
: 26829621
This position statement originated from a working group meeting convened on April 15, 2015, by the NHLBI and incorporates follow-up contributions by the participants as well as other thought leaders subsequently consulted, who together represent research fields relevant to all branches of the NIH. The group was deliberately composed not only of individuals with a current research emphasis in the glycosciences, but also of many experts from other fields, who evinced a strong interest in being involved in the discussions. The original goal was to discuss the value of creating centers of excellence for training the next generation of biomedical investigators in the glycosciences. A broader theme that emerged was the urgent need to bring the glycosciences back into the mainstream of biology by integrating relevant education into the curricula of medical, graduate, and postgraduate training programs, thus generating a critical sustainable workforce that can advance the much-needed translation of glycosciences into a more complete understanding of biology and the enhanced practice of medicine.
- Training the next generation of biomedical investigators in glycosciences
- Peter Agre - Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USACarolyn Bertozzi - Department of Chemistry, Stanford University, Stanford, California, USAMina Bissell - Lawrence Berkeley National Laboratory, Division of Biological Systems and Engineering, Berkeley, California, USAKevin P Campbell - Howard Hughes Medical Institute, Departments of Molecular Physiology and Biophysics, Neurology, and Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USARichard D Cummings - Department of Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USAUmesh R Desai - Department of Medicinal Chemistry and Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia, USAMary Estes - Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USATerence Flotte - Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USAGuy Fogleman - Federation of American Societies for Experimental Biology (FASEB), Bethesda, Maryland, USAFred Gage - Laboratory of Genetics LOG-G, The Salk Institute for Biological Studies, La Jolla, California, USADavid Ginsburg - Department of Internal Medicine, Department of Human Genetics, and Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USAJeffrey I Gordon - Center for Genome Sciences and Systems Biology, Washington University, St. Louis, Missouri, USAGerald Hart - Department of Biological Chemistry, Johns Hopkins University, Baltimore, Maryland, USAVincent Hascall - Department of Bioengineering, Cleveland Clinic Foundation, Cleveland, Ohio, USALaura Kiessling - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USAStuart Kornfeld - Department of Medicine, Washington University, St. Louis, Missouri, USAJohn Lowe - Department of Research Pathology, Genentech, South San Francisco, California, USAJohn Magnani - GlycoMimetics, Rockville, Maryland, USALara K Mahal - Biomedical Chemistry Institute, Department of Chemistry, New York University, New York, New York, USARuslan Medzhitov - Department of Immunobiology, Yale University, New Haven, Connecticut, USARichard J Roberts - New England BioLabs Inc., Ipswich, Massachusetts, USARobert Sackstein - Departments of Dermatology and Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USARita Sarkar - Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland, USARonald Schnaar - Departments of Pharmacology and Neuroscience, Johns Hopkins University, Baltimore, Maryland, USANancy Schwartz - Departments of Pediatrics and Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USAAjit Varki - Departments of Medicine and Cellular and Molecular Medicine, UCSD, San Diego, California, USADavid Walt - Tufts UniversityIrving Weissman - Institute for Stem Cell Biology and Regenerative Medicine, Ludwig Center for Cancer Stem Cell Research, Stanford University, Stanford, California, USA
- Journal article
- The Journal of clinical investigation, Vol.126(2), pp.405-408
- 10.1172/JCI85905
- 26829621
- PMC4731185
- J Clin Invest
- 0021-9738
- 1558-8238
- American Society for Clinical Investigation
- English
- 02/01/2016
- Neurology; Molecular Physiology and Biophysics; Iowa Neuroscience Institute
- 9984068373802771
24